Pharmacokinetic Profiles of Enrofloxacin and Its Metabolite Ciprofloxacin Administered by Different Doses in Calves
- 4 May 2026
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 49 (5) , 525-532
Abstract
This research studied dose‐dependent changes in the pharmacokinetics of enrofloxacin (ENR) and its active metabolite, ciprofloxacin (CIP), in calves. The research was performed on eighteen calves utilizing a parallel pharmacokinetic approach. Calves were divided into three distinct dosage groups, receiving intravenous administration of ENR at doses of 2.5, 5, and 10 mg/kg, respectively. Blood samples were collected at 15 specified intervals during a 48‐h duration. ENR and CIP plasma concentrations were quantified by HPLC. Pharmacokinetic data was obtained using non‐compartmental analysis. The area under the concentration‐time curve from 0 to last (AUC 0‐last )/dose of ENR increased in a dose‐dependent manner. The elimination half‐life of ENR was prolonged from 2.41 to 3.47 h ( p < 0.05). The total body clearance decreased significantly with the dose increase ( p < 0.05), while the volume of distribution at steady state remained comparable across dosage groups ( p > 0.05). The AUC 0‐last of CIP increased in a dose‐dependent manner ( p < 0.05), but no alteration was found in the conversion ratio of ENR to CIP (26%–28%, p > 0.05). The results of the current investigation demonstrated that the pharmacokinetics of ENR and CIP in calves had considerable variability with dose. Assessing dose‐dependent pharmacokinetic alterations in calves can aid in establishing the dosing regimen; however, additional research is required to confirm dose‐dependent therapeutic efficacy and safety.Keywords
This publication has 31 references indexed in Scilit:
- Pharmacokinetics of enrofloxacin and danofloxacin in premature calvesJournal of Veterinary Pharmacology and Therapeutics, 2019
- Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteriaJournal of Veterinary Pharmacology and Therapeutics, 2015
- Pharmacokinetic–pharmacodynamic (PK–PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugsVeterinary Microbiology, 2014
- Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacinResearch in Veterinary Science, 2010
- EnrofloxacinJournal of Exotic Pet Medicine, 2006
- Volumes of distributionJournal of Veterinary Pharmacology and Therapeutics, 2004
- Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicineJournal of Veterinary Pharmacology and Therapeutics, 2004
- Plasma clearanceJournal of Veterinary Pharmacology and Therapeutics, 2004
- The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibioticsResearch in Veterinary Science, 2002
- Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calvesJournal of Veterinary Pharmacology and Therapeutics, 1997